PTC Therapeutics, Inc. Shares Issued
PTC Therapeutics, Inc. (PTCT) had Shares Issued of 83.33 million shares as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Equity › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-07-30
- 2026-06-30: Common Stock, Shares, Issued 83.33M shares.
- 2026-03-31: Common Stock, Shares, Issued 82.88M shares.
- 2025-12-31: Common Stock, Shares, Issued 81.47M shares.
- 2025-09-30: Common Stock, Shares, Issued 79.93M shares.
| Period end | Common Stock, Shares, Issued |
|---|---|
| 2026-06-30 | 83.33M shares 10-Q · filed 2026-07-30 |
| 2026-03-31 | 82.88M shares 10-Q · filed 2026-05-07 |
| 2025-12-31 | 81.47M shares 10-Q · filed 2026-07-30 |
| 2025-09-30 | 79.93M shares 10-Q · filed 2025-11-04 |
| 2025-06-30 | 79.38M shares 10-Q · filed 2025-08-07 |
| 2025-03-31 | 79.23M shares 10-Q · filed 2025-05-06 |
| 2024-12-31 | 77.70M shares 10-K · filed 2026-02-19 |
| 2024-09-30 | 76.95M shares 10-Q · filed 2024-11-07 |
| 2024-06-30 | 76.90M shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 76.65M shares 10-Q · filed 2024-04-25 |
| 2023-12-31 | 75.71M shares 10-K · filed 2025-02-27 |
| 2023-09-30 | 75.46M shares 10-Q · filed 2023-10-26 |
| 2023-06-30 | 75.32M shares 10-Q · filed 2023-08-03 |
| 2023-03-31 | 74.01M shares 10-Q · filed 2023-04-27 |
| 2022-12-31 | 73.10M shares 10-K · filed 2024-02-29 |
| 2022-09-30 | 71.85M shares 10-Q · filed 2022-10-27 |
| 2022-06-30 | 71.51M shares 10-Q · filed 2022-08-04 |
| 2022-03-31 | 71.34M shares 10-Q · filed 2022-05-03 |
| 2021-12-31 | 70.83M shares 10-K · filed 2023-02-21 |
| 2021-09-30 | 70.67M shares 10-Q · filed 2021-10-28 |
| 2021-06-30 | 70.56M shares 10-Q · filed 2021-07-29 |
| 2021-03-31 | 70.41M shares 10-Q · filed 2021-05-04 |
| 2020-12-31 | 69.72M shares 10-K · filed 2022-02-22 |
| 2020-09-30 | 67.81M shares 10-Q · filed 2020-10-29 |
| 2020-06-30 | 67.24M shares 10-Q · filed 2020-08-05 |
| 2020-03-31 | 62.76M shares 10-Q · filed 2020-04-30 |
| 2019-12-31 | 61.94M shares 10-K · filed 2021-02-25 |
| 2019-09-30 | 61.58M shares 10-Q · filed 2019-10-30 |
| 2019-06-30 | 58.71M shares 10-Q · filed 2019-08-06 |
| 2019-03-31 | 58.42M shares 10-Q · filed 2019-05-02 |
| 2018-12-31 | 50.61M shares 10-K · filed 2020-03-02 |
| 2018-09-30 | 50.43M shares 10-Q · filed 2018-11-05 |
| 2018-06-30 | 46.68M shares 10-Q · filed 2018-08-07 |
| 2018-03-31 | 41.81M shares 10-Q · filed 2018-05-09 |
| 2017-12-31 | 41.61M shares 10-K · filed 2019-03-01 |
| 2017-09-30 | 41.46M shares 10-Q · filed 2017-11-02 |
| 2017-06-30 | 41.30M shares 10-Q · filed 2017-08-09 |
| 2017-03-31 | 34.32M shares 10-Q · filed 2017-05-08 |
| 2016-12-31 | 34.17M shares 10-K · filed 2018-03-06 |
| 2016-09-30 | 34.17M shares 10-Q · filed 2016-11-03 |
| 2016-06-30 | 34.08M shares 10-Q · filed 2016-08-04 |
| 2016-03-31 | 33.92M shares 10-Q · filed 2016-05-05 |
| 2015-12-31 | 33.92M shares 10-K · filed 2017-03-16 |
| 2015-09-30 | 33.92M shares 10-Q · filed 2015-11-09 |
| 2015-06-30 | 33.87M shares 10-Q · filed 2015-07-31 |
| 2015-03-31 | 33.48M shares 10-Q · filed 2015-05-05 |
| 2014-12-31 | 32.90M shares 10-K · filed 2016-02-29 |
| 2014-09-30 | 29.37M shares 10-Q · filed 2014-11-06 |
| 2014-06-30 | 29.34M shares 10-Q · filed 2014-08-07 |
| 2014-03-31 | 29.33M shares 10-Q · filed 2014-05-06 |
| 2013-12-31 | 23.80M shares 10-K · filed 2015-03-02 |
| 2013-09-30 | 23.80M shares 10-Q · filed 2013-11-14 |
| 2013-06-30 | 23.80M shares 10-Q · filed 2013-08-13 |
| 2012-12-31 | 4.53K shares 10-K · filed 2014-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |